Market Signal Briefing

SummaryCompaniesSato replaced by CFO Kenta Kon amid cost pressuresLeadership change reflects Toyota's strategic shiftToyota focuses on lowering break-even point amid tariffsTOKYO, Feb 20 (Reuters) - When Koji Sato was named Toyota CEO in 2023, he appeared to be the man for the moment: a veteran engineer who could give the world’s best-selling automaker a badly needed boost in electric vehicles. But after just three years in the top job, he is being replaced by Chief Financial Officer Kenta Kon, a close ally and former secretary of Chairman Akio Toyoda.

The management change, announced this month, will see Sato become Toyota's (7203.T), opens new tab vice chairman and chief industry officer from April. He delivered record sales and profit and, according to two people familiar with the matter, is regarded by suppliers and investors as a sharp and talented leader. Yet he will have had one of the shortest tenures on record for a Toyota boss.

Stay up to date with the latest news, trends and innovations that are driving the global automotive industry with the Reuters Auto File newsletter. Sign up here.

In recent months he was absent from some high-profile events that Toyoda attended, leading to speculation among executives about his future, according to three people. Two of the sources said there was no evidence of any falling-out between the men. The people declined to be identified because of the sensitivity of the issue.

Instead, the shake-up reflected Toyoda's thinking that his hand-picked successor was no longer the best fit for the job given mounting cost pressures, three people said. The grandson of Toyota's founder, Toyoda was CEO for almost 14 years prior to Sato.

This account contrasts with the explanation given by Sato at a press conference announcing the change and includes previously unreported details. In an on-stage interview with Toyota's own media outlet, Sato said Toyoda was not involved in the decision.

"Toyota keeps emphasising, over and over, that Akio Toyoda wasn’t involved in the personnel decision," said Seiji Sugiura, a senior analyst at Tokai Tokyo Intelligence Laboratory. "Mr. Sato also says the same thing very carefully – which means he probably was involved."

In a statement to Reuters, Toyota said that Toyoda was not a member of the group that determined executive appointments and not involved in the decision-making. That group had been discussing succession since last year and talks became more concrete when Sato's appointment as chairman of Japan's auto lobby was finalised in late 2025, it said.

After discussing with the group, Sato decided to step down and the proposal was then submitted to the board, Toyota said. Sato contributed to strengthening Toyota's finances and would be taking on multiple roles to address industry-wide challenges, it said.

TOYOTA FOCUSED ON BREAK-EVEN POINTThe leadership change came as the Japanese automaker was increasingly focused on tackling higher costs, partially due to U.S. tariffs, the three people said. Meanwhile, it needed to invest heavily in technology, two of them said. Although EVs were seen as a less immediate threat given cooling demand, Toyota executives were concerned that it was falling behind global rivals in software development, one of them said.

Kon, the incoming CEO, served as Toyoda's secretary for eight years and is known as the architect of a planned buyout of forklift maker Toyota Industries (6201.T), opens new tab. That deal, which would tighten the Toyoda family's grip on a key supplier, has drawn opposition from minority investors who say it lacks transparency and is significantly underpriced.

While automakers have been hit with billions of dollars in added expenses since Trump's tariffs took effect in April, Toyota has an additional burden, having pledged to take on higher costs faced by its suppliers. In recent years the automaker has focused more on its "break-even" point – the number of cars it needs to sell to cover its cost. Toyota sees lowering the break-even as an important gauge of management's ability, one person said.

"Over the past year or so, they’ve been talking a lot about needing to lower the break‑even point," said Sugiura, adding that could spell more cost-cutting under Kon.

Toyota doesn't make the break-even point public. It has a legendary reputation for squeezing costs through its philosophy of "kaizen", or continuous improvement, that identifies seven types of waste, including overproduction and defects.

In its statement, Toyota referred to comments by Kon at the same press conference, where he said Toyota must be "vigilant" to withstand even the most challenging external conditions. As CFO, Kon had been at the forefront of efforts to improve earnings, it said.

Kon is also CFO of Toyota's technology subsidiary, Woven by Toyota, where Toyoda's son, Daisuke, is a senior vice president.

Toyota said it expected to spend 360 billion yen ($2.3 billion) in the current financial year to help suppliers. It did not see the outlay as just a cost, it said, but an investment in improving competitiveness.

Toyota this month raised its full-year profit outlook by 12%, helped in part by cost-cutting. It has fared better than other automakers, thanks to its contrarian bet on gasoline-electric hybrids that now looks prescient.

($1 = 153.6700 yen)

Reporting by Maki Shiraki and Norihiko Shirouzu; Additional reporting by Daniel Leussink; Writing by David Dolan; Editing by Stephen Coates

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Opendoor Technologies Inc. (OPEN) Q4 2025 Earnings Call Transcript

NEEDHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the pricing of an underwritten public offering of 18,348,624 shares of its common stock at a price to the public of $5.45 per share. The gross proceeds to Candel from the offering are expected to be $100 million, before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on or about February 23, 2026, subject to customary closing conditions. In addition, Candel has granted the underwriters a 30-day option to purchase up to 2,752,293 additional shares of its common stock at the public offering price, less the underwriting discount.

Candel intends to use the net proceeds from the offering to complete critical launch readiness, medical affairs, pre-commercialization, and commercial activities for aglatimagene besadenovec (CAN-2409 or aglatimagene) in early, localized prostate cancer, ongoing development costs related to the phase 3 trial of aglatimagene in non-small cell lung cancer (NSCLC), and for general corporate purposes.

Citigroup, Cantor, and Stifel are acting as joint bookrunning managers for the offering. LifeSci Capital is acting as lead manager for the offering. H.C. Wainwright & Co. and Brookline Capital Markets, a division of Arcadia Securities, LLC, are acting as co-managers for the offering.

A shelf registration statement on Form S-3 relating to the shares of common stock offered in the public offering described above was filed with the Securities and Exchange Commission (the SEC) on August 14, 2025 and declared effective by the SEC on August 22, 2025. The offering is being made only by means of a written prospectus and prospectus supplement that form a part of the registration statement. A preliminary prospectus supplement and accompanying prospectus relating to the offering has been filed with the SEC and is available on the SEC’s website at www.sec.gov. A final prospectus supplement and accompanying prospectus will be filed with the SEC. When available, copies of the final prospectus supplement and the accompanying prospectus may also be obtained by contacting Citigroup Global Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, telephone: 1-800-831-9146; Cantor Fitzgerald & Co., Attention: Equity Capital Markets, 110 E. 59th Street, 6th Floor, New York, New York 10022 , or by email at [email protected]; or Stifel, Nicolaus & Company, Incorporated, Attention: Prospectus Department, One Montgomery Street, Suite 3700, San Francisco, California 94104, by telephone at (415) 364-2720 or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities being offered, nor shall there be any sale of the securities being offered in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About Candel Therapeutics

Candel is a clinical-stage biopharmaceutical company focused on developing off-the-shelf multimodal biological immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. Candel has established two clinical-stage multimodal biological immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) gene constructs, respectively. Aglatimagene is the lead product candidate from the adenovirus platform. The Company recently completed successful phase 2a clinical trials of aglatimagene in NSCLC and pancreatic ductal adenocarcinoma (PDAC), and a pivotal, placebo-controlled, phase 3 clinical trial of aglatimagene in localized prostate cancer, conducted under a Special Protocol Assessment agreed with the U.S. Food and Drug Administration (FDA). The FDA also granted Fast Track Designation and Regenerative Medicine Advanced Therapy Designation to aglatimagene for the treatment of newly diagnosed, localized prostate cancer in patients with intermediate- to high-risk disease, Fast Track Designation in NSCLC, and both Fast Track Designation and Orphan Drug Designation for the treatment of PDAC.

Linoserpaturev is the lead product candidate from the HSV platform and is currently in an ongoing phase 1b clinical trial in recurrent high-grade glioma. Finally, Candel’s enLIGHTEN™ Discovery Platform is a systematic, iterative HSV-based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapies for solid tumors.

Forward-Looking Statements

Various statements in this release concerning the timing and completion of the public offering on the anticipated terms or at all may constitute forward-looking statements for the purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995, as amended, and other federal securities laws. All such forward-looking statements are based on management’s current expectations of future events and are subject to a number of substantial risks and uncertainties, many of which are outside Candel’s control, that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include fluctuations in Candel’s stock price, changes in market conditions and satisfaction of customary closing conditions related to the public offering, as well as those risks more fully discussed in the section entitled “Risk Factors” in the prospectus supplement and registration statement referenced above, Candel’s Annual Report on Form 10-K for the year ended December 31, 2024, filed on March 13, 2025 with the SEC and subsequent filings with the SEC including Candel’s Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. There can be no assurance that Candel will be able to complete the public offering on the anticipated terms. Accordingly, you should not place undue reliance on these forward-looking statements. All such statements speak only as of the date made, and Candel undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, unless required by law.

Investor Contact:
Theodore Jenkins  
VP, Investor Relations and Business Development 
Candel Therapeutics, Inc. 
[email protected]

Media Contact:
Ben Shannon
Vice President
ICR Westwicke
[email protected]

NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Enphase Energy, Inc. (NASDAQ: ENPH) between April 22, 2025 and October 28, 2025, inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2026.

SO WHAT: If you purchased Enphase securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

WHAT TO DO NEXT: To join the Enphase class action, go to https://rosenlegal.com/submit-form/?case_id=25593 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than April 20, 2026. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved, at that time, the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Many of the firm’s attorneys have been recognized by Lawdragon and Super Lawyers.

DETAILS OF THE CASE: According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that: (1) Enphase overstated its ability to manage its channel inventory; (2) Enphase overstated its ability to mitigate effects arising from the termination of the Residential Clean Energy Credit; (3) accordingly, Enphase overstated its financial and operational prospects; and (4) as a result, Enphase’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.

To join the Enphase class action, go to https://rosenlegal.com/submit-form/?case_id=25593 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

-------------------------------

Contact Information:

        Laurence Rosen, Esq.
        Phillip Kim, Esq.
        The Rosen Law Firm, P.A.
        275 Madison Avenue, 40th Floor
        New York, NY 10016
        Tel: (212) 686-1060
        Toll Free: (866) 767-3653
        Fax: (212) 202-3827
        [email protected]
        www.rosenlegal.com

Mativ Holdings, Inc. (MATV) Q4 2025 Earnings Call Transcript

Travere Therapeutics, Inc. (TVTX) Q4 2025 Earnings Call Transcript

New York, New York--(Newsfile Corp. - February 19, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Boston Scientific Corporation ("Boston Scientific Corporation") (NYSE: BSX) concerning potential violations of the federal securities laws.

On February 4, 2026, Boston Scientific reported fourth-quarter 2025 results. While the company exceeded analyst expectations for earnings per share and total revenue, its electrophysiology segment reported sales of $890 million, approximately $43 million below the $933 million consensus estimate. The EP segment has been positioned as the primary growth engine for the company, driven by its FARAPULSE pulsed field ablation system and related cardiac rhythm management products.

The electrophysiology market represents one of the fastest-growing areas in cardiovascular medicine, with pulsed field ablation technology emerging as a potential replacement for traditional thermal ablation procedures. Boston Scientific entered this market through its acquisition of Farapulse in 2021 and has invested heavily in expanding manufacturing capacity and physician training programs. The company projected that global PFA penetration would reach 50% by the end of 2025 and grow to approximately 80% by 2028.

During the Q3 2025 earnings call on October 22, 2025, CEO Mike Mahoney stated the company was "guiding to organic growth of 11% to 13% for fourth quarter '25" and expressed that the company was "incredibly proud of our EP performance, with third quarter sales growing 63%." The company had emphasized EP growth rates of 94% in Q2 2025 and 63% in Q3 2025.

During the first Q&A exchange following the Q4 2025 earnings release, analysts noted the street was expecting approximately 25% EP growth for the quarter. Management's discussion indicated confidence in only approximately 15% growth going forward, representing a significant gap between market expectations and the company's internal outlook.

Following the earnings release, BSX shares fell 17.5% with the stock reaching a 52-week low of $75.50.

If you suffered a loss on your Boston Scientific Corporation securities and would like to explore a potential recovery under the federal securities laws, Learn More About the Investigation or contact Joseph E. Levi, Esq. via email at [email protected] or call (212)363-7500 to speak to our team of experienced shareholder advocates.

WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. Attorney Advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
33 Whitehall Street, 27th Floor
New York, NY 10004
[email protected]
Tel: (212)363-7500
Fax: (212)363-7171

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/284629

Source: Levi & Korsinsky, LLP

Five9, Inc. (FIVN) Q4 2025 Earnings Call Transcript

February 19, 2026 – TheNewswire - Golden Cariboo Resources Ltd. (CSE:GCC) (OTC:GCCFF) (WKN:A402CQ) (FSE:3TZ) (the “Company”) provides additional information to that included in the news release of February 11, 2026 regarding Interactive Offers.  Interactive Offers provides digital marketing and promotional services through online channels, including digital campaigns and content placement. Interactive Offers is arm’s length to the Company with no prior affiliation, ownership interest or other relationship.  Interactive Offers can be contacted at:

  Interactive Offers, LLC 

Address: 327 Plaza Real, Suite 319, Boca Raton, FL 33432, USA

Phone: +1 (844) 563-3377

Email: [email protected]

Website: www.interactiveoffers.com

    About Golden Cariboo Resources Ltd.

  Golden Cariboo Resources Ltd. is rediscovering the Cariboo Gold Rush by proceeding with highly targeted drilling and trenching programs on its Quesnelle Gold Quartz Mine property which is bordered by Osisko Development (NSE:ODV/TSXV:ODV), partly intertwined with them at the north end of the Cariboo Gold Project, and located along a favourable corridor adjacent to the Spanish and Eureka thrust faults over a 94,899 hectare (234,501 acre) area. Historically, over 101 placer gold creeks on the 90-kilometer (56 mile) trend, from the Cariboo Hudson mine north to the Quesnelle Gold Quartz Mine property, have recorded production with successful placer mining continuing to this day.

  Golden Cariboo’s Quesnelle Gold Quartz Mine property is 4 kilometers (2.5 miles) northeast of, and road accessible from, Hixon in central British Columbia. The Property includes the Quesnelle Quartz gold-silver deposit, which was discovered in 1865 and developed over a footprint of about 150m x 150m (< 6 acres) at the Main zone straddling Hixon Creek. Overall, the geological setting of the gold mineralization at the Company’s Quesnelle Gold Quartz Mine property shows strong similarities with the Spanish Mountain gold deposit, situated 120 km (75 miles) towards the southeast along the same geological trend. As a sediment-hosted vein (SHV) deposit, the Spanish Mountain deposit is considered to belong to the epizonal orogenic subclass of gold deposits which include some of the world’s largest deposits such as Muruntau, Uzbekistan and Bendigo, Australia.

   For further information please contact:

  GOLDEN CARIBOO RESOURCES LTD      

“J. Frank Callaghan”       

  J. Frank Callaghan, President & CEO

Tel:  604-669-6463

    

  VISIT OUR WEBSITE FOR MORE DETAILS

www.goldencariboo.com

LIKE AND FOLLOW

Instagram, Facebook, X (Twitter), LinkedIn

    Neither the “CSE” Canadian Securities Exchange nor its Regulation Service Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

  Cautionary Statements:

  This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and plans of the Company. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding; the expectation that the Company will receive all necessary exemptions and approvals to complete the Offering; the expectation that the Company will complete the Offering on the terms disclosed, or at all; the expectation that the proceeds will be used for property exploration and for general working capital; the Company’s exploration plans with respect to its Quesnelle Gold Quartz Mine property; and the anticipated participation of the insider in the Offering.

  Such forward-looking statements are based on a number of assumptions of management, including, without limitation, that the Company will receive all necessary exemptions and approvals to complete the Offering; that the Company will complete the Offering on the terms disclosed, or at all; that the proceeds will be used for property exploration and for general working capital; that the Company will have the resources required to proceed with its exploration plans; that the Company will not run into regulatory or other barriers in carrying out its business plans; that the insider will participate in the Offering, on the terms and conditions and in the amount currently expected by management; and that the Company will be able to rely on the exemption from the formal valuation and minority shareholder approval requirements on the basis anticipated.

  Additionally, forward-looking information involve a variety of known and unknown risks, uncertainties and other factors which may cause the actual plans, intentions, activities, results, performance or achievements of the Company to be materially different from any future plans, intentions, activities, results, performance or achievements expressed or implied by such forward-looking statements. Such risks include, without limitation: that the Company will not receive the necessary exemptions and approvals to complete the Offering; that the Company will not complete the Offering on the terms disclosed, or at all; that the Company will be unable to use the proceeds for property exploration and for general working capital; that the Company may incur unanticipated costs; that the Company may not have the resources required to pursue its exploration plans; that the Company’s operations could be adversely affected by possible future government legislation policies and controls or by changes in applicable laws and regulations; that the insider may not participate in the Offering on the terms and conditions and in the amount currently expected by management, or at all; and that the Company may not be able to rely on the exemption from the formal valuation and minority shareholder approval requirements on the basis currently expected. Such forward-looking information represents management’s best judgment based on information currently available. No forward-looking statement can be guaranteed and actual future results may vary materially. Accordingly, readers are advised not to place undue reliance on forward-looking statements or information. Neither the Company nor any of its representatives make any representation or warranty, express or implied, as to the accuracy, sufficiency or completeness of the information in this news release. Neither the Company nor any of its representatives shall have any liability whatsoever, under contract, tort, trust or otherwise, to you or any person resulting from the use of the information in this news release by you or any of your representatives or for omissions from the information in this news release.

  The forward-looking statements herein speak only as of the date they were originally made. The Company has no intention and undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

 

Savers Value Village (SVV - Free Report) reported $464.67 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 15.6%. EPS of $0.15 for the same period compares to $0.10 a year ago.

The reported revenue represents a surprise of -0.01% over the Zacks Consensus Estimate of $464.69 million. With the consensus EPS estimate being $0.16, the EPS surprise was -3.23%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Savers Value performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Comparable Store Sales Growth - Total: 5.4% versus 4.3% estimated by three analysts on average.Number of Stores - Total: 367 versus the two-analyst average estimate of 376.Number of Stores - United States: 179 versus the two-analyst average estimate of 186.Number of Stores - Canada: 170 versus 172 estimated by two analysts on average.Comparable Store Sales Growth - United States: 8.8% compared to the 6.4% average estimate based on two analysts.Comparable Store Sales Growth - Canada: 0.7% versus the two-analyst average estimate of 0.3%.U.S. Retail: $265.88 million versus $258.08 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +20.6% change.Other: $33.9 million versus the three-analyst average estimate of $34.18 million. The reported number represents a year-over-year change of +11.5%.Canada Retail: $164.89 million versus the three-analyst average estimate of $161.06 million. The reported number represents a year-over-year change of +9.1%.View all Key Company Metrics for Savers Value here>>>

Shares of Savers Value have returned +1.1% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

RingCentral (RNG - Free Report) reported $644.03 million in revenue for the quarter ended December 2025, representing a year-over-year increase of 4.8%. EPS of $1.18 for the same period compares to $0.98 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $642.29 million, representing a surprise of +0.27%. The company delivered an EPS surprise of +3.69%, with the consensus EPS estimate being $1.14.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how RingCentral performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Gross Margin - Non-GAAP Other: -10.6% versus the four-analyst average estimate of -9.5%.Gross Margin - Non-GAAP Subscriptions: 80.4% versus the four-analyst average estimate of 80.6%.Revenues- Subscriptions: $622.22 million versus the four-analyst average estimate of $621.84 million. The reported number represents a year-over-year change of +5.5%.Revenues- Other: $21.82 million compared to the $20.44 million average estimate based on four analysts. The reported number represents a change of -12.2% year over year.View all Key Company Metrics for RingCentral here>>>

Shares of RingCentral have returned +14.1% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

PTC Therapeutics (PTCT - Free Report) reported $164.68 million in revenue for the quarter ended December 2025, representing a year-over-year decline of 22.8%. EPS of -$1.67 for the same period compares to -$0.24 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $304.72 million, representing a surprise of -45.96%. The company delivered an EPS surprise of -700.58%, with the consensus EPS estimate being -$0.21.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how PTC Therapeutics performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Revenues- Net product revenue: $183.99 million versus the four-analyst average estimate of $174.53 million. The reported number represents a year-over-year change of +18.9%.Revenues- Royalty revenue: $79.39 million compared to the $70.77 million average estimate based on four analysts. The reported number represents a change of +36.5% year over year.Revenues- Net product revenue- Translarna: $39 million compared to the $40.42 million average estimate based on three analysts. The reported number represents a change of -58.4% year over year.Revenues- Net product revenue- Emflaza: $27.1 million versus $29.58 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -46.3% change.Revenues- Collaboration and license revenue: $-0.07 million versus $118.82 million estimated by two analysts on average.View all Key Company Metrics for PTC Therapeutics here>>>

Shares of PTC Therapeutics have returned -8.8% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

FORT PIERCE, FL / ACCESS Newswire / February 19, 2026 / Twin Vee PowerCats Co. (Nasdaq:VEEE), ("Twin Vee" or the "Company"), a manufacturer, distributor, and marketer of power sport boats, today announced the pricing of a best-efforts public offering of 6,383,000 shares of common stock. Each share of common is being sold at a public offering price of $0.47 per share. Total gross proceeds from the offering, before deducting placement agent fees and other offering expenses, are expected to be approximately $3 million. The offering is expected to close on February 23, 2026, subject to satisfaction of customary closing conditions.

The Company intends to use the net proceeds from the offering primarily for working capital and general corporate purposes.

ThinkEquity is acting as the sole placement agent for the offering.

A registration statement on Form S-1 (File No. 333-292661) relating to the securities was filed with the Securities and Exchange Commission ("SEC") and became effective on January 30, 2026, and a post-effective amendment to the registration statement became effective on February 13, 2026. This offering is being made only by means of a prospectus. Copies of the final prospectus, when available, may be obtained from ThinkEquity, 17 State Street, 41st Floor, New York, New York 10004. The final prospectus will be filed with the SEC and will be available on the SEC's website located at http://www.sec.gov.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Twin Vee PowerCats Co.

Twin Vee PowerCats Co. manufactures a range of boats under the Twin Vee and Bahama Boat Works brands, designed for activities including fishing, cruising, and recreational use. Twin Vee PowerCats are recognized for their stable, fuel-efficient, and smooth-riding catamaran hull designs. Twin Vee is one of the most recognizable brand names in the catamaran sport boat category and is known as the "Best Riding Boats on the Water™." Bahama Boat Works is an iconic luxury brand long celebrated for its unmatched craftsmanship, timeless aesthetic, and dedication to producing some of the finest offshore fishing vessels.

The Company is located in Fort Pierce, Florida, and has been building and selling boats for 30 years.

Learn more at twinvee.com and bahamaboatworks.com.

Forward-Looking Statements

This press release contains certain forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements are identified by the use of the words "could," "believe," "anticipate," "intend," "estimate," "expect," "may," "continue," "predict," "potential," "project" and similar expressions that are intended to identify forward-looking statements and include statements regarding the timing and completion of the proposed offering and the intended use of proceeds.

These forward-looking statements are based on management's expectations and assumptions as of the date of this press release and are subject to a number of risks and uncertainties, many of which are difficult to predict that could cause actual results to differ materially from current expectations and assumptions from those set forth or implied by any forward-looking statements. Important factors that could cause actual results to differ materially from current expectations include, among others, the Company's ability to consummate the offering and the risk factors described in the Company's Annual Report on Form 10-K for the year ended December 31, 2024, the Company's Quarterly Reports on Form 10-Q, the Company's Current Reports on Form 8-K and subsequent filings with the SEC. The information in this release is provided only as of the date of this release, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events, except as required by law.

Contact:
Glenn Sonoda
[email protected]

SOURCE: Twin Vee PowerCats Co.

Vancouver, British Columbia and Las Vegas, Nevada--(Newsfile Corp. - February 19, 2026) - Fairchild Gold Corp. (TSXV: FAIR) (FSE: Y4Y) (OTCQB: FCHDF) ("Fairchild" or the "Company"), is pleased to announce a non-brokered private placement financing (the "Offering"). The fully committed placement, the majority of which is being subscribed to by a North American Strategic Investor, is expected to close on February 20, 2026, subject to customary regulatory approvals.

The Offering will consist of approximately 13.8 million units (the "Units") at a price of C$0.09 per Unit, for total gross proceeds of C$1,242,000. Each Unit will consist of one common share in the capital of the Company (each, a "Share") and one common share purchase warrant (a "Warrant"). Each Warrant will entitle the holder to purchase one additional Share at a price of $0.15 per Share for a period of five years from closing of the Offering. The Warrants will include an acceleration clause stating that if the daily volume-weighted average closing price of the Common Shares on the TSX Venture Exchange is at least $0.50 per Common Share for a period of five (5) consecutive trading days, beginning 12 months after the closing date of the Offering (the "Triggering Event"), the Company may, within 5 days of the Triggering Event, accelerate the expiry date of the Warrants. Notice will be provided to the holders of the Warrants by way of a news release, and in such case, the Warrants will expire on the first day that is ten (10) calendar days after the date on which such notice is given.

The Offering is subject to all necessary regulatory approvals, including the approval of the TSX Venture Exchange. The securities issued under the Offering will be subject to a hold period under applicable securities laws in Canada expiring four months and one day from the closing date of the Offering. No finder's fees will be paid in connection with the Offering. Proceeds of the Offering will be used to advance the Company's Nevada gold projects and for general working capital purposes.

Nikolas Perrault, CFA, Executive Chairman of Fairchild, stated: "This rapidly executed financing led by a private North American based Strategic Investor is a yet another strong vote of confidence in the Company's focused value creation strategy and as it prepares for an acceleration of its efforts in Nevada over the next few months."

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.

About Fairchild Gold Corp.

Fairchild Gold Corp. is a public company engaged in the business of mineral exploration and development of copper, gold and silver assets in mining-friendly jurisdictions across North America.

The company is committed to identifying and developing high-quality resource properties in Nevada with strong geological resource potential. Its strategy focuses on creating long-term shareholder value through disciplined exploration, strategic partnerships, and responsible development practices.

Fairchild Gold's recently assembled trinity of Nevada properties includes Nevada Titan, Fairchild's flagship property, located in the Goodsprings Mining District, Nevada, an area known for historical high-grade copper-gold-PGEs mining. In more recent times, Nevada Titan was also highlighted for its near surface Antimony and Cobalt potential. That was followed by a MOU towards the acquisition of the Golden Arrow property in the prolific Walker Lane Shear Zone, encompassing two principal resource areas, Gold Coin and Hidden Hill, with a combined measured + indicated and inferred resource base outlined in an NI 43-101 report written by Mine Development Associates.

Finally, Fairchild's Carlin Queen property, an advanced-stage gold-silver project located at the intersection of the Carlin and Midas-Hollister gold trends. Fairchild Gold is leveraging the potential of all these three properties by utilizing the outstanding mineral resources support Nevada provides.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as the term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of this news release.

Cautionary Statement Regarding Forward-Looking Information

Certain information contained in this news release constitutes "forward-looking information" or "forward-looking statements" (collectively, "forward-looking information"). Without limiting the foregoing, such forward-looking information includes statements regarding the Company's business plans, expectations and objectives, and not limited to the closing of the Offering and receipt of all necessary approvals. In this news release, words such as "may", "would", "could", "will", "likely", "believe", "expect", "anticipate", "intend", "plan", "estimate" and similar words and the negative form thereof are used to identify forward-looking information. Forward-looking information should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. Forward-looking information is based on information available at the time and/or the Company management's good faith belief with respect to future events and is subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond the Company's control. For additional information with respect to these and other factors and assumptions underlying the forward-looking information made in this news release, see the Company's most recent Management's Discussion and Analysis and financial statements and other documents filed by the Company with the Canadian securities commissions and the discussion of risk factors set out therein. Such documents are available at www.sedarplus.ca under the Company's profile and on the Company's website, https://fairchildgold.com/. The forward-looking information set forth herein reflects the Company's expectations as at the date of this news release and is subject to change after such date. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Not for distribution to U.S. news wire services or for dissemination in the United States

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/284628

Source: Fairchild Gold Corp.

Ready to Announce with Confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us

Oil futures edged higher in early Asian trade amid ongoing U.S.-Iran tensions that could lead to supply disruptions.

GraniteShares 2x Long NVDA Daily ETF offers leveraged daily exposure to Nvidia, suitable only for experienced traders seeking short-term trades. I see NVDA's growth underpinned by hyperscaler capital outlays, ongoing GPU/CPU replacement cycles, and gradual enterprise AI adoption, despite market uncertainty. Custom silicon deals by hyperscalers raise competitive questions, but I expect NVDA to maintain leadership amid surging AI infrastructure investment.

Lundin Mining (LUNMF - Free Report) came out with quarterly earnings of $0.42 per share, beating the Zacks Consensus Estimate of $0.3 per share. This compares to earnings of $0.12 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +40.80%. A quarter ago, it was expected that this base metals mining company would post earnings of $0.15 per share when it actually produced earnings of $0.18, delivering a surprise of +20%.

Over the last four quarters, the company has surpassed consensus EPS estimates three times.

Lundin, which belongs to the Zacks Mining - Non Ferrous industry, posted revenues of $1.3 billion for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 13.06%. This compares to year-ago revenues of $858.9 million. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Lundin shares have added about 20% since the beginning of the year versus the S&P 500's gain of 0.5%.

What's Next for Lundin?While Lundin has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Lundin was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $0.27 on $1.09 billion in revenues for the coming quarter and $1.07 on $4.17 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Mining - Non Ferrous is currently in the top 31% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Another stock from the same industry, Ero Copper Corp. (ERO - Free Report) , has yet to report results for the quarter ended December 2025. The results are expected to be released on March 5.

This company is expected to post quarterly earnings of $1.06 per share in its upcoming report, which represents a year-over-year change of +523.5%. The consensus EPS estimate for the quarter has been revised 15.3% higher over the last 30 days to the current level.

Ero Copper Corp.'s revenues are expected to be $293.5 million, up 139.6% from the year-ago quarter.

, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ardent Health, Inc. ("Ardent" or the "Company") (NYSE: ARDT). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether Ardent and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

You have until March 9, 2026 to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Ardent securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.        

[Click here for information about joining the class action]

On November 12, 2025, Ardent revealed a $43 million decrease in third quarter 2025 revenue.  The decrease resulted from revised determinations of accounts receivable collectability after the Company transitioned to a new revenue accounting system and from purported "recently completed hindsight evaluations of historical collection trends."  The new system—called the Kodiak RCA net revenue platform—provided management with "additional information to more precisely" determine accounts receivable collectability, including "more timely consideration of payor denial and payment trends."  Ardent revealed that the new system "recognizes reserves earlier in an account's life cycle" compared to the Company's prior collectability framework, which "had utilized a 180-day cliff at which time an account became fully reserved."  Ardent also announced a cut to 2025 EBITDA guidance of $57.5 million at the midpoint, or about 9.6%, from $575 million – $625 million to $530 million – $555 million because of "persistent industry-wide cost pressures," including "payer denials."  In addition, Ardent recorded a $54 million increase in professional liability reserves "with respect to recent settlements and ongoing litigation arising from a limited set of claims between 2019 and 2022 in New Mexico" as well as "consideration of broader industry trends, including social inflationary pressures."  On this news, Ardent's stock price fell $4.75 per share, or 33.81%, to close at $9.30 per share on November 13, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com.

Attorney advertising.  Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980

SOURCE Pomerantz LLP

, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Endeavor Group Holdings, Inc. ("Endeavor" or the "Company") (NYSE: EDR). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

The class action concerns whether Endeavor and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

You have until March 18, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you sold Endeavor Class A common stock during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.   

[Click here for information about joining the class action]  

A Complaint has been filed on behalf of a class consisting of all investors who sold Endeavor Class A common stock between January 15, 2025 and March 24, 2025, against Endeavor, certain of its officers and directors, and Silver Lake Group, L.L.C. (together, the "Defendants").  The Complaint alleges that the Defendants orchestrated a unified scheme to depress minority bargaining power and the value realizable by the unaffiliated public shareholders, while insiders captured future upside through rollovers and separate benefits.  Defendants allegedly orchestrated this scheme by, among other things: (i) rejecting a "majority of the minority" vote on the merger and closing by controller written consent; (ii) locking-in a $27.50 cash-out merger consideration without any collar or contingent value right and offering only a de minimis dividend to shareholders that they shared with themselves; and (iii) disseminating a misleading Information Statement on January 15, 2025 that spoke in present tense about "fairness" and "best interests" to unaffiliated shareholders while relying on Centerview Partners, LLC's fairness opinion with analysis frozen "as of" March 2024 and omitting material contemporaneous information needed to render those assertions not misleading.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. 

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980 

SOURCE Pomerantz LLP

, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE: BBWI). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

The class action concerns whether Bath & Body Works and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

You have until March 16, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Bath & Body Works securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.   

[Click here for information about joining the class action]  

On August 28, 2025, Bath & Body Works reported its second quarter 2025 financial results.  Among other items, the Company reported earnings per diluted share of $0.30, representing a decline of 55.8% year over year and missing the Company's prior guidance on the low end by $0.03.  Bath & Body Works also reported net income of $64 million, a decline of 57.9% year over year.  The Company also announced that it was cutting its full year guidance for earnings per diluted share by $0.03 at the midpoint, to a range of $3.28 to $3.53. 

On this news, Bath & Body Works' stock price fell $2.18 per share, or 6.9%, to close at $29.36 per share on August 28, 2025. 

Then, on November 20, 2025, Bath & Body Works reported third quarter 2025 financial results.  The Company reported a 1% year over year decline in revenue, missing its guidance of 1-3% growth for the quarter.  Bath & Body Work's net income also declined, falling 26% to $77 million.  Finally, the Company announced that it was slashing full year guidance for net sales from a previously positive 1.5%-2.7% to negative "high single digits."  Bath & Body Works also cut expected earnings per diluted share from a range of $3.28 to $3.53 to "at least $2.83."  In an investor presentation published the same day, the Company announced a new business strategy and admitted that its strategy of "adjacencies, collaborations and promotions" had "not grown our total customer base." 

On this news, Bath & Body Works' stock price fell $5.22 per share, or 24.8%, to close at $15.82 per share on November 20, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. 

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980 

SOURCE Pomerantz LLP

, /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Ramaco Resources, Inc. ("Ramaco" or the "Company") (NASDAQ: METC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. 

The class action concerns whether Ramaco and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. 

You have until March 31, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Ramaco securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.   

[Click here for information about joining the class action]  

On October 23, 2025, Wolfpack Research published a report alleging, among other things, that Ramaco's Brook Mine in northern Wyoming is a "hoax" and a "Potemkin Mine" which was not, in fact, mined after its July groundbreaking.  The report alleges that the Company "built this mine for show," and purports to reveal that, as shown by drone footage taken three months after the mine's opening, no active work appears to have occurred.  The report states that "[d]espite multiple site visits during working hours over several weeks" Wolfpack researchers "never observed the equipment mentioned in news reports or any active work." 

On this news, Ramaco Resources' stock price fell $3.81 per share, or 9.57%, to close at $36.01 per share on October 23, 2025.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomlaw.com. 

Attorney advertising. Prior results do not guarantee similar outcomes.  

CONTACT:
Danielle Peyton
Pomerantz LLP
[email protected]
646-581-9980 ext. 7980 

SOURCE Pomerantz LLP

Consolidated Edison (ED - Free Report) reported $4 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 8.9%. EPS of $0.89 for the same period compares to $0.98 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $3.7 billion, representing a surprise of +8.07%. The company delivered an EPS surprise of +5.59%, with the consensus EPS estimate being $0.84.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Con Ed performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Operating revenues- O&R: $306 million versus the three-analyst average estimate of $261.09 million. The reported number represents a year-over-year change of +13.3%.Operating revenues- CECONY: $3.69 billion versus $3.46 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +8.5% change.Operating Income- CECONY: $484 million versus $600.96 million estimated by three analysts on average.Operating Income- O&R: $21 million versus $26.49 million estimated by three analysts on average.Operating Income- Con Edison Transmission: $-20 million compared to the $-1.93 million average estimate based on two analysts.Operating Income- Other: $2 million compared to the $11.51 million average estimate based on two analysts.View all Key Company Metrics for Con Ed here>>>

Shares of Con Ed have returned +7.5% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Texas Roadhouse (TXRH - Free Report) reported $1.48 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 3.1%. EPS of $1.28 for the same period compares to $1.73 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $1.5 billion, representing a surprise of -1.24%. The company delivered an EPS surprise of -16.5%, with the consensus EPS estimate being $1.53.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Texas Roadhouse performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Comparable restaurant sales growth - Company restaurants: 4.2% versus the seven-analyst average estimate of 5.2%.Restaurants at the end - Company - Total: 714 compared to the 714 average estimate based on five analysts.Restaurants at the end - Total: 816 compared to the 817 average estimate based on five analysts.Number of restaurants opened - Franchise: 1 compared to the 1 average estimate based on four analysts.Store weeks - Company restaurants: 9,224 versus 9,227 estimated by four analysts on average.Restaurants at the end - Franchise - Total: 102 versus 103 estimated by four analysts on average.Franchise-owned restaurants-Comparable restaurant sales growth: 5.3% versus the four-analyst average estimate of 5.5%.Number of restaurants opened - Company: 9 compared to the 10 average estimate based on four analysts.Store weeks - Franchise restaurants: 1,242 compared to the 1,348 average estimate based on four analysts.Number of restaurants opened - Total: 10 versus 11 estimated by four analysts on average.Revenue- Franchise royalties and fees: $8.22 million versus $8.49 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a -10% change.Revenue- Restaurant and other sales: $1.47 billion versus $1.49 billion estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +3.2% change.View all Key Company Metrics for Texas Roadhouse here>>>

Shares of Texas Roadhouse have returned -2.4% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Opendoor Technologies Inc. (OPEN - Free Report) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.08. This compares to a loss of $0.11 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +15.97%. A quarter ago, it was expected that this company would post a loss of $0.07 per share when it actually produced a loss of $0.08, delivering a surprise of -14.29%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Opendoor Technologies, which belongs to the Zacks Internet - Software industry, posted revenues of $736 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 23.41%. This compares to year-ago revenues of $1.08 billion. The company has topped consensus revenue estimates four times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Opendoor Technologies shares have lost about 20.6% since the beginning of the year versus the S&P 500's gain of 0.5%.

What's Next for Opendoor Technologies?While Opendoor Technologies has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Opendoor Technologies was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is -$0.07 on $871.95 million in revenues for the coming quarter and -$0.21 on $4.61 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Internet - Software is currently in the top 36% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

One other stock from the same industry, Compass, Inc. (COMP - Free Report) , is yet to report results for the quarter ended December 2025. The results are expected to be released on February 26.

This company is expected to post quarterly loss of $0.06 per share in its upcoming report, which represents a year-over-year change of +25%. The consensus EPS estimate for the quarter has been revised 53.2% lower over the last 30 days to the current level.

Compass, Inc.'s revenues are expected to be $1.68 billion, up 21.6% from the year-ago quarter.

For the quarter ended December 2025, American Coastal Insurance (ACIC - Free Report) reported revenue of $86.38 million, up 9% over the same period last year. EPS came in at $0.51, compared to $0.12 in the year-ago quarter.

The reported revenue represents a surprise of +3.56% over the Zacks Consensus Estimate of $83.41 million. With the consensus EPS estimate being $0.42, the EPS surprise was +21.43%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how American Coastal performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Loss Ratio: 12.5% compared to the 23.8% average estimate based on two analysts.Expense Ratio: 46.1% compared to the 45% average estimate based on two analysts.Combined Ratio: 58.6% versus 68.8% estimated by two analysts on average.Net premiums earned: $79.32 million versus the two-analyst average estimate of $76.91 million. The reported number represents a year-over-year change of +7.9%.Net investment income: $5.49 million versus the two-analyst average estimate of $5.8 million. The reported number represents a year-over-year change of +3.1%.View all Key Company Metrics for American Coastal here>>>

Shares of American Coastal have returned -2.1% over the past month versus the Zacks S&P 500 composite's -0.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.